Mycoplasma-associated carditis. Case reports and review

Cardiology. 2002;97(2):83-8. doi: 10.1159/000057677.

Abstract

We present 2 cases and examine the developments that occurred in diagnosis, treatment, and outcome of 19 additional patients with mycoplasmal peri- and myocarditis. The mean age of this group was 33 years. The final diagnoses were pericarditis (n = 15), myocarditis (n = 5), and myopericarditis (n = 1); pulmonary involvement was noted in 13 patients. Serology established the diagnosis in 12 cases, and isolation in 9 others. In contrast to previous reviews, an echocardiogram was carried out in all patients, thus enabling pericardiocentesis in 13 patients. Antibiotics were given to 19 patients, including 4 who received a newer macrolide. Three patients were left with long-term sequelae, and 1 patient died. The outcome of Mycoplasma carditis has improved over the years, although a minority of patients may suffer long-term sequelae.

Publication types

  • Case Reports
  • Review

MeSH terms

  • Adult
  • Anti-Bacterial Agents / therapeutic use
  • Anti-Inflammatory Agents / therapeutic use
  • Antibodies, Bacterial / blood
  • Clarithromycin / therapeutic use
  • Drug Therapy, Combination
  • Enzyme-Linked Immunosorbent Assay
  • Female
  • Humans
  • Immunoglobulin M / blood
  • Mycoplasma Infections* / drug therapy
  • Mycoplasma pneumoniae* / immunology
  • Myocarditis / drug therapy
  • Myocarditis / microbiology*
  • Pericarditis / drug therapy
  • Pericarditis / microbiology*
  • Prednisone / therapeutic use

Substances

  • Anti-Bacterial Agents
  • Anti-Inflammatory Agents
  • Antibodies, Bacterial
  • Immunoglobulin M
  • Clarithromycin
  • Prednisone